litlas
ログインアカウント作成

Jane C. Davies

1988–2025 年に発表

別表記
Jane C Davies
122
論文数
19,349
被引用数
65
h 指数
115
i10 指数

被引用数

Jane C. Davies の年別被引用数1989 年: 被引用 3 件1990 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 3 件1993 年: 被引用 2 件1994 年: 被引用 4 件1995 年: 被引用 2 件1996 年: 被引用 1 件1997 年: 被引用 2 件1998 年: 被引用 3 件1999 年: 被引用 5 件2000 年: 被引用 15 件2001 年: 被引用 12 件2002 年: 被引用 11 件2003 年: 被引用 7 件2004 年: 被引用 14 件2005 年: 被引用 14 件2006 年: 被引用 9 件2007 年: 被引用 7 件2008 年: 被引用 21 件2009 年: 被引用 33 件2010 年: 被引用 48 件2011 年: 被引用 63 件2012 年: 被引用 92 件2013 年: 被引用 136 件2014 年: 被引用 138 件2015 年: 被引用 139 件2016 年: 被引用 199 件2017 年: 被引用 193 件2018 年: 被引用 199 件2019 年: 被引用 765 件2020 年: 被引用 894 件2021 年: 被引用 915 件2022 年: 被引用 747 件2023 年: 被引用 654 件2024 年: 被引用 911 件2025 年: 被引用 390 件2026 年: 被引用 5 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,682 件、この内訳の 24.1%イギリス: 引用元論文 827 件、この内訳の 11.9%ドイツ: 引用元論文 411 件、この内訳の 5.9%オーストラリア: 引用元論文 368 件、この内訳の 5.3%カナダ: 引用元論文 368 件、この内訳の 5.3%イタリア: 引用元論文 360 件、この内訳の 5.2%中国: 引用元論文 357 件、この内訳の 5.1%フランス: 引用元論文 304 件、この内訳の 4.4%オランダ: 引用元論文 236 件、この内訳の 3.4%スイス: 引用元論文 184 件、この内訳の 2.6%アイルランド: 引用元論文 154 件、この内訳の 2.2%ベルギー: 引用元論文 143 件、この内訳の 2.1%
0%24.1%その他 22.5%

機関

分野

  • Medicine60.5%
  • Biochemistry, Genetics and Molecular Biology26.7%
  • Immunology and Microbiology3.6%
  • Environmental Science2.2%
  • Engineering1.1%
  • Health Professions1.1%
  • その他4.8%

トピック

  • Cystic Fibrosis Research Advances15.4%
  • Neonatal Respiratory Health Research6.4%
  • Asthma and respiratory diseases5%
  • Gut microbiota and health4.2%
  • Pediatric health and respiratory diseases3.2%
  • Tracheal and airway disorders2.8%
  • その他63%

共著者

全論文

検索で開く
  1. The future of cystic fibrosis care: a global perspective

    著者: Scott C Bell, Marcus A Mall, Hector Gutierrez, Milan Macek, Susan Madge, Jane C Davies, Pierre-Régis Burgel, Elizabeth Tullis, Claudio Castaños, Carlo Castellani, Catherine A Byrnes, Fiona Cathcart, Sanjay H Chotirmall, Rebecca Cosgriff, Irmgard Eichler, Isabelle Fajac, Christopher H Goss, Pavel Drevinek, Philip M Farrell, Anna M Gravelle, Trudy Havermans, Nicole Mayer-Hamblett, Nataliya Kashirskaya, Eitan Kerem, Joseph L Mathew, Edward F McKone, Lutz Naehrlich, Samya Z Nasr, Gabriela R Oates, Ciaran O'Neill, Ulrike Pypops, Karen S Raraigh, Steven M Rowe, Kevin W Southern, Sheila Sivam, Anne L Stephenson, Marco Zampoli, Felix Ratjen - The Lancet Respiratory Medicine 2019 被引用: 961

  2. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane

    著者: Akshay Sabnis, Katheryn LH Hagart, Anna Klöckner, Michele Becce, Lindsay E. Evans, R. Christopher D. Furniss, Despoina A. I. Mavridou, Ronan A. Murphy, Molly M. Stevens, Jane C. Davies, Gerald Larrouy‐Maumus, Thomas B. Clarke, Andrew M. Edwards - eLife 2021 被引用: 391

  3. Cystic fibrosis

    著者: Michal Shteinberg, Iram Haq, Deepika Polineni, Jane C. Davies - The Lancet 2021 被引用: 651

  4. Disordered Microbial Communities in Asthmatic Airways

    著者: Markus Hilty, Conor M. Burke, Helder Pedro, Paúl Cárdenas, Andy Bush, Cara Bossley, Jane C. Davies, Aaron Ervine, Len W. Poulter, Lior Pachter, Miriam F. Moffatt, William Cookson - PLoS ONE 2010 被引用: 1,836

  5. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

    著者: Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney, Elizabeth Tullis, Scott C. Bell, Pavel Dřevínek, Matthias Griese, Edward F. McKone, Claire Wainwright, Michael W. Konstan, Richard B. Moss, Félix Ratjen, Isabelle Sermet‐Gaudelus, Steven M. Rowe, Qunming Dong, Sally Rodriguez, Karl Yen, Claudia L. Ordoñez, J.S. Elborn - New England Journal of Medicine 2011 被引用: 2,174

  6. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR

    著者: Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey, Gautham Marigowda, Xiaohong Huang, Marco Cipolli, Carla Colombo, Jane C. Davies, K. De Boeck, Patrick A. Flume, Michael W. Konstan, Susanna A. McColley, Karen McCoy, Edward F. McKone, À. Munck, Félix Ratjen, Steven M. Rowe, David Waltz, Michael Boyle - New England Journal of Medicine 2015 被引用: 1,621

  7. A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

    著者: Edith T. Zemanick, Jennifer L. Taylor‐Cousar, Jane C. Davies, Ronald L. Gibson, Marcus Mall, Edward F. McKone, Paul McNally, Bonnie W. Ramsey, Jonathan H. Rayment, Steven M. Rowe, Elizabeth Tullis, Neil Ahluwalia, Chenghao Chu, Thang Ho, Samuel M. Moskowitz, Sabrina Noël, Simon Tian, David Waltz, Tanya G. Weinstock, Fengjuan Xuan, Claire Wainwright, Susanna A. McColley - American Journal of Respiratory and Critical Care Medicine 2021 被引用: 288

  8. Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study

    著者: Marcus Mall, Rossa Brugha, Silvia Gärtner, Julian Legg, Alexander Mœller, Pedro Mondéjar-López, Dario Prais, Tacjana Pressler, Félix Ratjen, Philippe Reix, Paul D. Robinson, Hiran Selvadurai, Florian Stehling, Neil Ahluwalia, Emilio Arteaga‐Solis, Bote G. Bruinsma, Mark T. Jennings, Samuel M. Moskowitz, Sabrina Noël, Simon Tian, Tanya G. Weinstock, Pan Wu, Claire Wainwright, Jane C. Davies - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 140

  9. Future therapies for cystic fibrosis

    著者: Lucy Allen, Lorna Allen, S.B. Carr, Gwyneth Davies, D.G. Downey, Marie E. Egan, Julian Forton, Robert D. Gray, Charles Haworth, Alex Horsley, Alan R Smyth, Kevin W Southern, Jane C. Davies - Nature Communications 2023 被引用: 134

  10. Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

    著者: Steven M. Rowe, Cori Daines, Felix C. Ringshausen, Eitan Kerem, John Wilson, Elizabeth Tullis, Nitin Nair, C Simard, Linda K. Han, Edward P. Ingenito, Charlotte McKee, Julie Lekstrom-Himes, Jane C. Davies - New England Journal of Medicine 2017 被引用: 511

  11. Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial

    著者: Paul McNally, Karen Lester, Gavin Stone, B. Elnazir, Michael Williamson, D. Cox, Barry Linnane, L. Kirwan, David Rea, Paul O’Regan, Tom Semple, Clare Saunders, Harm A.W.M. Tiddens, Edward F. McKone, Jane C. Davies - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 84

  12. Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Clinical Trial

    著者: Claire Wainwright, Susanna A. McColley, Paul McNally, Michael R. Powers, Félix Ratjen, Jonathan H. Rayment, George Retsch‐Bogart, Erica A. Roesch, Neil Ahluwalia, Anna Chin, Chenghao Chu, Mengdi Lu, Prema R. Menon, David Waltz, Tanya G. Weinstock, L. Zelazoski, Jane C. Davies - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 65

  13. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

    著者: Eric W.F.W. Alton, David K Armstrong, Deborah Ashby, Katie J Bayfield, Diana Bilton, Emily V Bloomfield, A. Christopher Boyd, June Brand, Ruaridh Buchan, Roberto Calcedo, Paula Carvelli, Mario Chan, Seng H. Cheng, David Collie, Steve Cunningham, Heather Davidson, Gwyneth Davies, Jane C. Davies, Lee A. Davies, Maria H Dewar, Ann Doherty, Jackie Donovan, Natalie S Dwyer, Hala I Elgmati, Rosanna F Featherstone, Jemyr Gavino, Sabrina Gea‐Sorlí, Duncan M. Geddes, James Sr Gibson, Deborah R. Gill, A P Greening, Uta Griesenbach, David M. Hansell, Katharine Harman, Tracy Higgins, Samantha L. Hodges, Stephen C. Hyde, Laura Hyndman, J. Alastair Innes, Joseph Jacob, Nancy E. Jones, Brian F Keogh, Maria P. Limberis, Paul Lloyd-Evans, Alan Maclean, Michelle C Manvell, Dominique McCormick, Michael McGovern, Gerry McLachlan, Cuixiang Meng, M Angeles Montero, Hazel Milligan, Laura Moyce, Gordon Murray, Andrew G. Nicholson, Tina Osadolor, Javier Parra-Leiton, David J. Porteous, Ian A. Pringle, Emma K Punch, Kamila M Pytel, Alexandra L. Quittner, Gina Rivellini, Clare Saunders, Ronald K. Scheule, Sarah Sheard, Nicholas J. Simmonds, Keith Smith, Stephen N. Smith, Najwa Soussi, Samia Soussi, Emma J Spearing, Barbara Stevenson, Stephanie Jones, Minna Turkkila, Rosa P Ureta, Michael D Waller, Marguerite Y Wasowicz, James M. Wilson, Paul Wolstenholme-Hogg - The Lancet Respiratory Medicine 2015 被引用: 424

  14. TheStaphylococcus aureusNetwork Adaptive Platform Trial Protocol: New Tools for an Old Foe

    著者: Steven Y. C. Tong, Jocelyn Mora, Asha C Bowen, Matthew P. Cheng, Nick Daneman, Anna L. Goodman, George Heriot, Todd C. Lee, Roger Lewis, David Chien Lye, Robert K. Mahar, Julie Marsh, Anna McGlothlin, Zoe McQuilten, Susan C. Morpeth, David L. Paterson, David J. Price, Jason Roberts, James O. Robinson, Sebastiaan J. van Hal, Genevieve Walls, Steve Webb, Lyn Whiteway, Dafna Yahav, Joshua S. Davis, for the Staphylococcus aureus Network Adaptive Platform (SNAP) Study Group, Nick Anagnostou, Sophia Archuleta, Eugene Athan, Lauren Barina, Emma Best, Max Bloomfield, Jennifer Bostock, Carly L. Botheras, Asha C Bowen, Philip N Britton, Hannah J. Burden, Anita J Campbell, Hannah Carter, Matthew P. Cheng, Ka Lip Chew, Russel Lee Ming Chong, Geoffrey W. Coombs, Peter Daley, Nick Daneman, Jane C. Davies, Joshua S. Davis, Yael Dishon, Ravindra Dotel, Adrian Dunlop, Felicity Flack, Katie L. Flanagan, Hong Foo, Nesrin Ghanem‐Zoubi, Stefano Giulieri, Anna L. Goodman, Jennifer Grant, Dan Gregson, Stephen Guy, Amanda Gwee, Erica Hardy, Andrew Henderson, George Heriot, Benjamin P. Howden, Fleur Hudson, Jennie Johnstone, Shirin Kalimuddin, Dana de Kretser, Andrea Lay‐Hoon Kwa, Todd A. Lee, Amy Legg, Roger Lewis, Martin Llewelyn, Thomas Lumley, David Chien Lye, Derek R. MacFadden, Robert K. Mahar, Isabelle Malhamé, Michael Marks, Julie Marsh, Marianne Martinello, Gail Matthews, Colin McArthur, Anna McGlothlin, Genevieve McKew, Brendan McMullan, Zoe McQuilten, Eliza Milliken, Jocelyn Mora, Susan C. Morpeth, Srinivas Murthy, Clare Nourse, Matthew O’Sullivan, David L. Paterson, Mical Paul, Neta Petersiel, Lina Petrella, Sarah Pett, David J. Price, Jason Roberts ほか 27 名 - Clinical Infectious Diseases 2022 被引用: 101

  15. A Cell-Free Biosensor for Detecting Quorum Sensing Molecules in P. aeruginosa-Infected Respiratory Samples

    著者: Ke Yan Wen, Loren Cameron, James Chappell, Kirsten Jensen, David Bell, Richard Kelwick, Margarita Kopniczky, Jane C. Davies, Alain Filloux, Paul S. Freemont - ACS Synthetic Biology 2017 被引用: 169

  16. Standards for the care of people with cystic fibrosis; establishing and maintaining health

    著者: Kevin W Southern, C. Addy, Scott C. Bell, Amanda Bevan, Urzula Borawska, Catherine Brown, Pierre‐Régis Burgel, Brenda Button, Carlo Castellani, A. Chansard, Mark Chilvers, Gwyneth Davies, Jane C. Davies, K. De Boeck, Dimitri Declercq, Michael Doumit, Pavel Dřevı́nek, Isabelle Fajac, Silvia Gärtner, Anna M. Georgiopoulos, Sandra Gursli, Andrea Gramegna, C. Hansen, Martin J. Hug, Elise Lammertyn, Edwina C. Landau, Ross Langley, Nicole Mayer-Hamblett, Anna Middleton, Peter G. Middleton, M. Mielus, Lisa Morrison, À. Munck, Barry J. Plant, M. Ploeger, Dominique Bertrand, Tacjana Pressler, Bradley S. Quon, Thomas Radtke, Zoe L. Saynor, Ilan Shufer, Alan R Smyth, Chris Smith, Silke van Koningsbruggen‐Rietschel - Journal of Cystic Fibrosis 2023 被引用: 81

  17. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study

    著者: Jane C. Davies, Steve Cunningham, William T. Harris, Allen Lapey, Warren E. Regelmann, Gregory S. Sawicki, Kevin W Southern, Sarah Robertson, Yulia Green, Jon Cooke, Margaret Rosenfeld - The Lancet Respiratory Medicine 2016 被引用: 345

  18. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

    著者: Margaret Rosenfeld, Claire Wainwright, Mark Higgins, Linda T. Wang, Charlotte McKee, Daniel Campbell, Simon Tian, Jennifer Schneider, Steve Cunningham, Jane C. Davies, Margaret Rosenfeld, Claire Wainwright, Mark Higgins, Linda T. Wang, Charlotte McKee, Daniel Campbell, Simon Tian, Jennifer Schneider, Steve Cunningham, Jane C. Davies, William T. Harris, Peter J. Mogayzel, Karen McCoy, Carlos Milla, Ronald C. Rubenstein, Seth Walker, Philip Black, Gregory S. Montgomery, Susanna A. McColley, Peter Hiatt, Gregory S. Sawicki, Michael J. Rock, Paul Aurora, Félix Ratjen, Anirban Maitra, Andrew Ives, Erol Gaillard, Paul McNalley, Hiranjan Selvadurai, Philip Robinson - The Lancet Respiratory Medicine 2018 被引用: 270

  19. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

    著者: Ahmet Uluer, Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall, Edward F. McKone, Bonnie W. Ramsey, Steven M. Rowe, Ronald C. Rubenstein, Jennifer L. Taylor‐Cousar, Elizabeth Tullis, Lael M. Yonker, Chenghao Chu, Anna P. Lam, Nitin Nair, Patrick R. Sosnay, Simon Tian, Fredrick Van Goor, Lakshmi Viswanathan, David Waltz, Linda T. Wang, Yingmei Xi, Joanne Billings, Alex Horsley, Alex Horsley, E.F. Nash, Marleen Bakker, Renske van der Meer, Petrus Merkus, Christof J. Majoor, Karen McCoy, Joanne Billings, Krishna Pancham, James Tolle, Bryon Quick, Ahmet Uluer, Emily DiMango, Adupa Rao, Santiago Reyes, Ross C. Klingsberg, Celeste Barreto, Victor E. Ortega, Donna Beth Willey‐Courand, C. Schwarz, Sivagurunathan Sutharsan, Rainald Fischer, Jane C. Davies, J. Duckers, Alex Horsley, Simon Doe, E.F. Nash, Marleen Bakker, Harry Heijerman, Renske van der Meer, Petrus Merkus, Christof J. Majoor, George M. Solomon, Christian A. Merlo, Jennifer Griffonnet, Joseph M. Pilewski, Jordan Dunitz, Saba Sheikh, Ronald C. Rubenstein, Daniel Rosenbluth, Theodore G. Liou, M.V. Indihar, Krishna Pancham, Lael M. Yonker, Samya Z. Nasr, Jennifer Griffonnet, Cynthia D. Brown, Gregory S. Sawicki, Jennifer Ruddy, Emily DiMango, Bryan Garcia, Andrew T. Braun, Alex H. Gifford, Nighat Mehdi, Maria Tupayachi Ortiz, Raksha Jain, Francisco J. Calimano, Jimmy Johannes, Cori Daines, Jason Fullmer, Joel Mermis, Christopher Barrios, Ngoc P. Ly, Brian Casserly, Stephan Eisenmann, Helge Hebestreit, Alexander Kiefer, Sivagurunathan Sutharsan, Rainald Fischer, Gordon MacGregor, D. Peckham, M.J. Ledson, Eva Van Braeckel, Petrus Merkus, Noel G. McElvaney ほか 6 名 - The Lancet Respiratory Medicine 2023 被引用: 64

  20. Cystic fibrosis

    著者: Marcus Mall, Pierre‐Régis Burgel, Carlo Castellani, Jane C. Davies, Matthias Salathé, Jennifer L. Taylor‐Cousar - Nature Reviews Disease Primers 2024 被引用: 168

  21. Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis

    著者: Kevin W Southern, Carlo Castellani, Elise Lammertyn, Alan R Smyth, Donald R. VanDevanter, Silke van Koningsbruggen‐Rietschel, Jürg Barben, Amanda Bevan, Edwin J. Brokaar, Sarah Collins, Gary Connett, T. Daniels, Jane C. Davies, Dimitri Declercq, Silvia Gärtner, Andrea Gramegna, Naomi Hamilton, Jenny Hauser, N. Kashirskaya, Laurence Kessler, J. Lowdon, Halyna Makukh, Clémence Martin, Lisa Morrison, D. Nazareth, Jacquelien Noordhoek, Ciarán O’Neill, E. Owen, H. Oxley, Karen S. Raraigh, Caroline Raynal, Karen A. Robinson, Jobst Roehmel, Carsten Schwarz, Isabelle Sermet‐Gaudelus, Michal Shteinberg, Ian Sinha, Constance Takawira, Peter van Mourik, Marieke Verkleij, Michael D Waller, Alistair Duff - Journal of Cystic Fibrosis 2022 被引用: 69

  22. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence

    著者: Jane C. Davies - Paediatric Respiratory Reviews 2002 被引用: 298

  23. Pseudomonas aeruginosainfection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches

    著者: Helena Lund‐Palau, A R Turnbull, Andrew Bush, Emmanuelle Bardin, Loren Cameron, Odel Soren, Natasha Wierre-Gore, Eric W.F.W. Alton, Jacob G. Bundy, Gary Connett, Saul N. Faust, Alain Filloux, Paul S. Freemont, Andy Jones, Valerie Khoo, Sandra Morales, Ronan A. Murphy, Rishi Pabary, A. Simbo, Silke Schelenz, Zoltán Takáts, Jeremy S. Webb, Huw D. Williams, Jane C. Davies - Expert Review of Respiratory Medicine 2016 被引用: 170

  24. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)

    著者: Jürg Barben, Carlo Castellani, À. Munck, Jane C. Davies, Karin M. de Winter‐de Groot, Silvia Gärtner, N. Kashirskaya, Barry Linnane, Sarah Mayell, Susanna A. McColley, Chee Y. Ooi, Marijke Proesmans, Clement L. Ren, Danieli B. Salinas, Dorota Sands, Isabelle Sermet‐Gaudelus, Olaf Sommerburg, Kevin W Southern - Journal of Cystic Fibrosis 2020 被引用: 121